PE giants Apollo, Bain Capital and Advent International are keen to pick stake in Viom
Experts say a turnaround may happen after the general elections.
New regime places more limits on unregulated foreign entities
For the past few years, Avigo has been in talks with many strategic players, including private equity investors, to sell its stake in Spykar.
Smaller players may find it difficult to bear the costs associated with such a requirement.
According to industry estimates, the sector's revenue would increase eight-10 per cent in 2013-14, against 12 per cent in 2012-13.
Three closed-ended equity schemes have been launched in the past month or so and another is set to open soon for subscription.
While some companies, such as HSBC, have closed retail operations, big players such as India Infoline is scaling down.
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
The 91.9 per cent slide in the stock price of Gitanjali Gems since April has depleted the value of promoter Mehul Choksi's holding in the company by at least Rs 17 crore (Rs 170 million) a day on an average.
The exchange may now look to its real estate business for cash flows
Sahara says awaiting further clarity on issue from regulator, suggests 'human error' or investor confusion led to mismatch.
The value of the index, adjusted from its all-time high for the relative loss in the rupee's value, is close to sub-10,000 levels.
Global private equity (PE) major Carlyle is in talks with renowned cardiac surgeon Dr Naresh Trehan to acquire a minority stake in his Gurgaon-based multi-super speciality hospital, Medanta -The Medicity.
Indian investments in equity and debt account for the second-highest remittances outgo (about a quarter).
Indian firm to soon launch copycat of anti-breast-cancer drug.
.jpg)
The Companies Bill asked for promoting gender diversity by specifying induction of a minimum number of women directors
No respite in sight as not many big deals, initial public offerings in pipeline.
With response tepid so far from domestic investors, these funds might soon approach FIPB for approvals.
Despite slowdown, smaller firms attract growth capital.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances